Dr. Muna Al Maslamani, Medical Director of the Communicable Disease Center at Hamad Medical Corporation (HMC), has pointed out that a new medicine is being adopted for COVID-19 patients in the case of emergencies.

This information had been communicated through video footage which has been shared on HMC’s Twitter account.

جولة مع الدكتورة \ منى المسلماني ..
للتعرف على الخدمات التي تقدم بمركز الأمراض الإنتقالية في ظل جائحة #كورونا @HMC_Qatar https://t.co/PVHIzwmXr2

— مؤسسة حمد الطبية (@HMC_Qatar) April 16, 2021

According to Dr. Muna Al Maslamani, HMC has adopted a new medicine for COVID-19 patients where only a single dose is required. Moreover, this dose is given to the infected patient directly through their vein.

She also explained that this treatment is being given to stop the reproduction of the virus in the body and will only be allowed in the case of emergencies. Patients who are in need of this treatment are accurately identified when providing healthcare. 

Speaking about the function of the Communicable Disease Center (CDC), Dr. Al Maslamani said that it is one of the most important centers for receiving COVID-19 cases in Qatar.

Dr. Al Maslamani said the center comprises about 65 beds with separate rooms. “The center offers many services like laboratory tests for those suspected of coming in contact with COVID-19 infected people. The center also runs a vaccination unit providing COVID-19 vaccine to individuals following schedule,” said Dr. Al Maslamani.

She said the center also offers the service of triage as all patients in Qatar with positive cases from 45 years old and above come to the center to undergo evaluation.

For more information on HMC, please visit their website.

Visit our Ramadan Page for more useful information about the Holy Month!

---

Make sure to check out our social media to keep track of the latest content.

Instagram - @qatarliving

Twitter - @qatarliving

Facebook - Qatar Living

YouTube - qatarlivingofficial

Source: The Peninsula